Apollo Hospitals Enterprise Limited has announced its 45th Annual General Meeting (AGM) scheduled for Tuesday, August 25, 2026, at 10:15 A.M. IST, to be held through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company has also released its Annual Report for FY 2025-26, along with the Business Responsibility and Sustainability Report, pursuant to Regulations 30, 34 and 53(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance for FY 2025-26

Apollo Hospitals delivered strong financial results for the year ended March 31, 2026. The following table summarises the key financial metrics on both standalone and consolidated bases:

On a standalone basis, revenue from operations grew 13% to ₹93,262 million, while profit after tax increased 15% to ₹14,926 million. On a consolidated basis, revenue grew 16% to ₹252,285 million and profit after tax rose 33% to ₹20,027 million. Consolidated EBITDA increased 25% to ₹37,693 million for the year.

Dividend Declaration

The Board of Directors has recommended a Final Dividend of ₹10 per equity share (200%) of face value of ₹5 each for the financial year ended March 31, 2026. An interim dividend of ₹10 per equity share was paid on February 27, 2026, involving a gross amount of ₹1,437.85 million. The total dividend for the financial year, including the proposed final dividend, amounts to ₹20 per equity share and will aggregate to ₹2,875.70 million (400% on the face value of ₹5 per equity share).

AGM Agenda and Key Resolutions

The 45th AGM will transact both ordinary and special business. Key items on the agenda include:

• Adoption of audited standalone and consolidated financial statements for FY 2025-26
• Confirmation of interim dividend and approval of final dividend
• Re-appointment of Smt. Sangita Reddy (DIN: 00006285) and Dr. Prathap C Reddy (DIN: 00003654) as retiring directors
• Re-appointment of Dr. Prathap C Reddy as Whole-time Director designated as Executive Chairman for a period of two years with effect from June 25, 2026 up to June 24, 2028
• Re-appointment of Smt. Rama Bijapurkar (DIN: 00001835) as an Independent Director for a second term of five consecutive years commencing from November 12, 2026 to November 11, 2031
• Issuance of Non-Convertible Debentures on a Private Placement Basis for a sum up to ₹7,500 million
• Ratification of remuneration payable to M/s. A.N. Raman & Associates, Cost Accountants, Chennai (FRN 102111) amounting to ₹1.65 million plus applicable statutory levies for FY ending March 31, 2027

Key Corporate Developments

During FY 2025-26, Apollo Hospitals progressed several strategic initiatives:

• The Board approved a Composite Scheme of Arrangement involving Apollo Hospitals Enterprise Limited, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. The Competition Commission of India accorded its approval on September 23, 2025, and BSE Limited and NSE issued observation letters in December 2025.
• The Board approved a proposal for Apollo Health and Lifestyle Limited (AHLL) to combine with Kids Clinic India Limited (Cloudnine) to create one of India's largest maternity and fertility care platforms, valuing the relevant businesses at approximately ₹15,500 million.
• The Board approved the merger of Apollo Hospitals North Limited into Apollo Hospitals Enterprise Limited, subject to statutory and regulatory approvals.

Operational and Credit Highlights

The company's network comprised over 10,900 beds across 78 hospitals, with over 47 million registered users on the Apollo 24/7 digital platform and over 7,200 pharmacies. Shareholders' wealth increased at a compounded average annual growth rate of 40% over the last five years, compared to 16% CAGR for the Nifty 50 index. ROCE on a consolidated basis (excluding Capital WIP) improved from 20% in FY24 to 23.7% in FY26. The company maintained a robust credit profile with long-term ratings of ICRA AAA Stable, CRISIL AA+ Positive, and India Rating IND AA+/Positive.

E-Voting and AGM Participation

The remote e-voting period commences on Saturday, August 22, 2026 (9:00 a.m. IST) and ends on Monday, August 24, 2026 (5:00 p.m. IST). The cut-off date for determining eligibility to vote is Tuesday, August 18, 2026. NSDL has been appointed as the authorised agency for facilitating electronic voting. Members may join the AGM through VC/OAVM 30 minutes before the scheduled time on a first-come-first-served basis for up to 1,000 members, with large shareholders, promoters, institutional investors, and directors permitted to attend without restriction.

A notable block trade involving apollo hospitals was recorded on the Bombay Stock Exchange (BSE), with the transaction aggregating to ₹44.19 crore. The deal was executed at a price of ₹8,900.00 per share, covering approximately 49,647 shares.

Block Trade Details

The following table summarises the key parameters of the block trade:

Block trades of this scale are typically executed between institutional participants and are carried out outside the regular order book to minimise market impact. The transaction reflects notable activity in Apollo Hospitals shares on the BSE.